Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3523)
All Articles published online
|
Publishing Process of This Article
|
Jan 27, 2023 (publication date) through Nov 8, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Surgery
ISSN
1948-9366
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Li J, Yang F, Li J, Huang ZY, Cheng Q, Zhang EL. Postoperative adjuvant therapy for hepatocellular carcinoma with microvascular invasion. World J Gastrointest Surg 2023; 15(1): 19-31 [PMID: 36741072 DOI: 10.4240/wjgs.v15.i1.19] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i1/19.htm |
| Number | Citing Articles |
| 1 |
Tamer A. Addissouky, Ibrahim El Tantawy El Sayed, Majeed M. A. Ali, Yuliang Wang, Ayman El Baz, Ahmed A. Khalil, Naglaa Elarabany. Latest advances in hepatocellular carcinoma management and prevention through advanced technologies. Egyptian Liver Journal 2024; 14(1) doi: 10.1186/s43066-023-00306-3
|
| 2 |
Zhuoya Sun, Biao Gao, Lai Song, Biying Wang, Junfeng Li, Hao Jiang, Xuerui Li, Yang Yu, Zishan Zhou, Zizhong Yang, Xiaohui Sun, Tianyu Jiao, Xiao Zhao, Shichun Lu, Shunchang Jiao. Single-cell RNA sequencing reveals intratumoral heterogeneity and multicellular community in primary hepatocellular carcinoma underlying microvascular invasion. Heliyon 2024; 10(18): e37233 doi: 10.1016/j.heliyon.2024.e37233
|
| 3 |
Bowen Men, Huzhe Cui, Zhezhu Han, Xiuying Jin, Qiang Xu, Yongmin Jin, Zhengri Piao, Songnan Zhang. Evaluation of the efficacy of transarterial chemoembolization combined with microwave ablation followed by adjuvant therapy in patients with hepatocellular carcinoma. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1337396
|
| 4 |
Junyu Wu, Guoyi Tang, Chien-Shan Cheng, Ranna Yeerken, Yau-Tuen Chan, Zhiwen Fu, Yi-Chao Zheng, Yibin Feng, Ning Wang. Traditional Chinese medicine for the treatment of cancers of hepatobiliary system: from clinical evidence to drug discovery. Molecular Cancer 2024; 23(1) doi: 10.1186/s12943-024-02136-2
|
| 5 |
Er-lei Zhang. Editorial: Immunomodulatory factors, conversion, and postoperative adjuvant therapy for hepatobiliary tumors based on immunotherapy. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1218845
|
| 6 |
Han Wang, Jun-Jie Chen, Shu-Yi Yin, Xia Sheng, Hong-Xia Wang, Wan Yee Lau, Hui Dong, Wen-Ming Cong. A Grading System of Microvascular Invasion for Patients with Hepatocellular Carcinoma Undergoing Liver Resection with Curative Intent: A Multicenter Study. Journal of Hepatocellular Carcinoma 2024; : 191 doi: 10.2147/JHC.S447731
|